Publication | Open Access

Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells

Regenerative MedicineDevelopmental BiologyMedicineAdult Stem CellBiological AgeStem Cell ResearchStem-cell TherapyMesenchymal Stem CellStem CellsCell BiologyCell SignalingLeptin Receptor/cd295